Tags

Type your tag names separated by a space and hit enter

Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain.
Am J Kidney Dis. 1994 Dec; 24(6):907-11.AJ

Abstract

Angiotensin-converting enzyme inhibitors (ACEIs) have been suggested to reduce interdialytic fluid weight gain, presumably via suppression of the dipsogenic angiotensin II. We retrospectively studied 25 (76% black) chronic hemodialysis patients who received ACEIs for blood pressure control. The mean arterial blood pressure decreased from 115.4 +/- 10.4 mm Hg to 112.7 +/- 9.0 mm Hg (mean +/- SD; P = NS) and there was no change in the interdialytic weight gain (3.74 +/- 1.5 kg v 3.72 +/- 1.5 kg; P = NS). Only 10 (40%) patients had some reduction in their interdialytic weight gain; in four of them the reduction was more than 20% of the pre-ACEI weight gain. When nine patients who had no decline in blood pressure were excluded due to possible noncompliance, the mean arterial blood pressure in the remaining 16 patients (75% black) declined from 119.3 +/- 9.9 mm Hg to 111.6 +/- 9.9 mm Hg (P < 0.0001), but there was no change in the interdialytic fluid weight gain (3.7 +/- 1.4 kg v 3.8 +/- 1.4 kg; P = NS). There was no correlation between age, race, etiology of renal failure, or blood pressure response and change in the interdialytic weight gain after ACEI treatment. Our results do not support the previous report that ACEIs significantly decrease the interdialytic weight gain in chronic hemodialysis patients. The multifactorial nature of excessive fluid intake in the hemodialysis patients and the differences in patient population and study design may account for this discrepancy.

Authors+Show Affiliations

Division of Nephrology, St Louis University Medical Center, MO.No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

7985667

Citation

Bastani, B, and J Redington. "Lack of Efficacy of Angiotensin-converting Enzyme Inhibitors in Reducing Interdialytic Weight Gain." American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, vol. 24, no. 6, 1994, pp. 907-11.
Bastani B, Redington J. Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain. Am J Kidney Dis. 1994;24(6):907-11.
Bastani, B., & Redington, J. (1994). Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 24(6), 907-11.
Bastani B, Redington J. Lack of Efficacy of Angiotensin-converting Enzyme Inhibitors in Reducing Interdialytic Weight Gain. Am J Kidney Dis. 1994;24(6):907-11. PubMed PMID: 7985667.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Lack of efficacy of angiotensin-converting enzyme inhibitors in reducing interdialytic weight gain. AU - Bastani,B, AU - Redington,J, PY - 1994/12/1/pubmed PY - 1994/12/1/medline PY - 1994/12/1/entrez SP - 907 EP - 11 JF - American journal of kidney diseases : the official journal of the National Kidney Foundation JO - Am J Kidney Dis VL - 24 IS - 6 N2 - Angiotensin-converting enzyme inhibitors (ACEIs) have been suggested to reduce interdialytic fluid weight gain, presumably via suppression of the dipsogenic angiotensin II. We retrospectively studied 25 (76% black) chronic hemodialysis patients who received ACEIs for blood pressure control. The mean arterial blood pressure decreased from 115.4 +/- 10.4 mm Hg to 112.7 +/- 9.0 mm Hg (mean +/- SD; P = NS) and there was no change in the interdialytic weight gain (3.74 +/- 1.5 kg v 3.72 +/- 1.5 kg; P = NS). Only 10 (40%) patients had some reduction in their interdialytic weight gain; in four of them the reduction was more than 20% of the pre-ACEI weight gain. When nine patients who had no decline in blood pressure were excluded due to possible noncompliance, the mean arterial blood pressure in the remaining 16 patients (75% black) declined from 119.3 +/- 9.9 mm Hg to 111.6 +/- 9.9 mm Hg (P < 0.0001), but there was no change in the interdialytic fluid weight gain (3.7 +/- 1.4 kg v 3.8 +/- 1.4 kg; P = NS). There was no correlation between age, race, etiology of renal failure, or blood pressure response and change in the interdialytic weight gain after ACEI treatment. Our results do not support the previous report that ACEIs significantly decrease the interdialytic weight gain in chronic hemodialysis patients. The multifactorial nature of excessive fluid intake in the hemodialysis patients and the differences in patient population and study design may account for this discrepancy. SN - 0272-6386 UR - https://www.unboundmedicine.com/medline/citation/7985667/Lack_of_efficacy_of_angiotensin_converting_enzyme_inhibitors_in_reducing_interdialytic_weight_gain_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0272638694002441 DB - PRIME DP - Unbound Medicine ER -